Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

EGCG may help regrow hair by inhibiting a specific enzyme.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

GLI2 activates GLI1, promoting skin tumor growth and hair development.

Prostaglandin E2 promotes skin cancer, but certain supplements and drugs may help reduce risk and improve treatment.

Activating telomerase can boost hair follicle stem cell growth and hair production.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Skin reactions from cancer treatments might predict how well the treatments work.

Hedgehog pathway inhibitors could be effective in treating melanoma.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Epidermal growth factor slows hair and body growth in mice.

TB and BCC tumors show similar follicular differentiation patterns.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Korean Red Ginseng may help prevent hair loss from chemotherapy.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Tofacitinib might be used to treat hair loss.

EGF, IGF-I, and IGF-IR genes are crucial for mink skin and hair growth.

CD34 is crucial for skin tumor development in mice.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

The FDA approved a new Pfizer drug for hair loss in teens.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

Oncogenic melanocyte stem cells can develop into melanoma similar to human cases.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

E6/E7 oncogenes in hair follicles cause continuous hair growth by skipping the resting phase.

Targeting PTEN can improve healing in venous leg ulcers.